This clinical trial will evaluate the efficacy of two types of high-power prism glasses that provide field of view expansion for patients with homonymous hemianopia (the complete loss of half the field of vision on the same side in both eyes).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Improvement in Blind-side Detection Rate for Hazards Approaching at a Bearing Angle of 40 Degrees
Timeframe: Immediately after each 4-week intervention